Evidence map›Paper›PMID 33042783›Full record

ArticleLaboratory animal research2020

Unexpected effects of ivermectin and selamectin on inducible Cre

Peter A Kropp, Gabrielle V Rushing, Asa A Brockman, Erin N Z Yu, Rebecca A Ihrie, Maureen Gannon

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Laboratory animal research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Peter A KroppDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN USA.ORCID 0000-0002-2977-6123
Gabrielle V RushingNeuroscience Program, Vanderbilt University, Nashville, TN USA.
Asa A BrockmanDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN USA.
Erin N Z YuDepartment of Pathology, Immunology and Microbiology, Vanderbilt University Medical Center, Nashville, TN USA.
Rebecca A IhrieNeuroscience Program, Vanderbilt University, Nashville, TN USA.
Maureen GannonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN USA.
Vanderbilt University · USNational Institutes of Health · USTennessee Valley Authority · USVanderbilt University Medical Center · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCERT32CA009592 · NCI · VANDERBILT UNIVERSITY · PI Justin M Balko, Julie A Rhoades (Sterling) · 1987 to 2026
$10.4M
Formation and maturation of endocrine pancreas progenitorsR01DK105689 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GANNON, MAUREEN A, STOFFERS, DORIS A · 2016 to 2019
$2.2M
Quantifying Differences in mTOR Activity and Tumor Development Between Neural Stem Cell MicrodomainsR01NS096238 · NINDS · VANDERBILT UNIVERSITY · PI IHRIE, REBECCA A · 2016 to 2020
$1.7M
LSM880-Airyscan Confocal Microscope for Large Shared ResourceS10OD021630 · OD · VANDERBILT UNIVERSITY · PI WELLS, K. SAM · 2016 to 2016
$560k
Investigating the Effects of Stem Cell Positional Identity on Brain Tumor DevelopmentF31NS096908 · NINDS · VANDERBILT UNIVERSITY · PI RUSHING, GABRIELLE · 2017 to 2019
$76k
BLRD VA I01 BX003744NCI NIH HHS P30 CA068485NCI NIH HHS T32 CA009592NEI NIH HHS P30 EY008126NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK105689NIDDK NIH HHS U24 DK059637NIH HHS S10 OD021630NINDS NIH HHS F31 NS096908NINDS NIH HHS R01 NS096238
6 · The paper itself

Abstract

backgroundAnti-parasitics are frequently used in research animal facilities to treat a multitude of common infections, with pinworms and fur mites being amongst the most common. Ivermectin and selamectin are common oral and topical treatments for these infections, respectively. Although commonly thought to be innocuous to both the research animals and any transgenic elements that the animals may carry, evidence exists that ivermectin is capable of activating the recombinase activity of at least one Cre CASE PRESENTATION: We analyzed the offspring of transgenic mice exposed to either ivermectin or selamectin during pregnancy and nursing. Through analysis of reporter genes co-expressed with multiple, independently generated transgenic Cre

conclusionsAlthough the mechanisms by which ivermectin and selamectin affect Cre

Indexed as

CreERIvermectinSelamectinTransgenic mice

Identifiers

PMID33042783
PMCPMC7542348
OpenAlexW3091808300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.